2m 2m 2m 2m 2m 2m 2m
INTELLIGENT (INBS)
NASDAQ
$2.51+$0.07 (+2.87%)
Price as of Jun 04, 2026 7:11 AM EDT- $6.1MMarket Cap
- -84.56%1-Year Change
- Medical DevicesIndustry
INTELLIGENT (INBS)
$2.51+$0.07 (+2.87%)
Annual
Quarterly
06/30/2025 | 06/30/2024 | 06/30/2023 | 06/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 3.1M -1.90% | 3.1M +147.58% | 1.3M +187.52% | 437,146 -77.93% | |
Cost of Revenue | 1.8M +7.09% | 1.7M +81.27% | 930,204 N/A | N/A N/A | |
Gross Profit | 1.2M -12.54% | 1.4M +336.41% | 326,668 -25.27% | 437,146 -77.93% | |
Sales and Marketing Expense | 1.6M N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 970,117 -0.43% | 974,355 +19.63% | 814,481 N/A | N/A N/A | |
Total Operating Expenses | 12.7M +4.74% | 12.1M -11.17% | 13.7M +55.68% | 8.8M +16.15% | |
Operating Profit | -10.6M +3.51% | -10.3M -18.36% | -12.6M +51.08% | -8.3M +49.58% | |
Interest Income | 101,522 +19.69% | 84,822 +776.62% | 9,676 -32.93% | 14,426 +4.49% | |
Interest Expense | N/A N/A | -167,140 -25.23% | -223,534 +2,865.04% | -7,539 -99.31% | |
Interest Income and Expense and Net | 101,522 +223.33% | -82,318 -61.51% | -213,858 -3,205.24% | 6,887 +100.64% | |
Total Nonoperating Income and Expense | 271,780 +194.64% | 92,242 -95.22% | 1.9M +66,475.10% | 2,900 +100.20% | |
Income before Taxes | -10.6M +3.51% | -10.3M -18.36% | -12.6M +51.08% | -8.3M +18.08% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 4.2M N/A | N/A N/A | |
Net Income | -10.6M +4.06% | -10.2M -4.47% | -10.6M +28.00% | -8.3M +18.03% | |
Net Income from Continuing Operations Applicable to Common | -10.6M +4.06% | -10.2M -4.47% | -10.6M +28.00% | -8.3M +17.65% | |
Basic EPS and Net Income | -2.00 -68.65% | -6.38 -39.70% | -10.58 +1,756.14% | -0.57 -16.18% | |
Diluted EPS and Net Income | -2.00 -68.65% | -6.38 -39.70% | -10.58 +1,756.14% | -0.57 -16.18% | |
Basic Weighted Average Shares | 5.3M +231.10% | 1.6M +58.55% | 1.0M -93.15% | 14.7M +40.81% | |
Diluted Weighted Average Shares | 5.3M +231.10% | 1.6M +58.55% | 1.0M -93.15% | 14.7M +40.81% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.0M -83.82% | 6.3M +310.09% | 1.5M -81.34% | 8.2M -34.48% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.0M -83.82% | 6.3M +310.09% | 1.5M -81.34% | 8.2M -34.48% | |
Total Current Assets | 4.1M -51.51% | 8.5M +120.95% | 3.9M +417.24% | 746,761 -95.90% | |
Accumulated Depreciation | 88,164 +45.07% | 60,775 +79.97% | 33,769 -91.37% | 391,408 N/A | |
Property and Plant and Equipment and Net | 251,325 -55.58% | 565,850 -18.01% | 690,175 +76.33% | 391,408 N/A | |
Total Long-Term Assets | 251,325 -55.58% | 565,850 -18.01% | 690,175 +76.33% | 391,408 -22.34% | |
Total Assets | 8.2M -40.13% | 13.8M +33.07% | 10.4M N/A | N/A N/A | |
Income Taxes Payable | 84,806 -94.05% | 1.4M 0.00% | 1.4M +56.77% | 909,187 +711.25% | |
Total Short-Term Debt | 197,146 -61.74% | 515,282 +45.89% | 353,211 N/A | N/A N/A | |
Total Current Liabilities | 5.4M -1.83% | 5.5M -7.36% | 5.9M +81.03% | 3.3M -11.74% | |
Total Long-Term Debt | 1.6M 0.00% | 1.6M +309.57% | 402,862 N/A | N/A N/A | |
Total Long-Term Liabilities | 1.7M +2,033.02% | 81,324 -89.29% | 759,027 N/A | N/A N/A | |
Total Liabilities | 5.4M -2.85% | 5.6M -16.08% | 6.7M N/A | N/A N/A | |
Retained Earnings | -62.5M +20.34% | -52.0M +24.29% | -41.8M +34.10% | -31.2M +36.32% | |
Total Stockholders Equity | 3.0M -64.03% | 8.3M +119.25% | 3.8M -41.96% | 6.5M -56.53% | |
Total Shares Outstanding | 7.3M +111.90% | 3.5M +48.30% | 2.3M -84.35% | 14.9M +9.63% | |
Cash Flow | |||||
Cash from Operating Activities | -9.7M +1.10% | -9.6M +29.74% | -7.4M +119.69% | -3.4M -70.27% | |
Capital Expenditures | 231,838 +4,218.89% | 5,368 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -231,838 +4.70% | -221,426 -68.10% | -694,142 -21.14% | -880,221 N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 4.6M -68.42% | 14.6M +914.44% | 1.4M N/A | N/A N/A | |
Financials Ratio | |||||
Gross Margin | 40.85% -10.84% | 45.81% +76.27% | 25.99% N/A | N/A N/A | |
Operating Margin | -348.71% +5.52% | -330.46% -67.02% | -1,002.11% -47.45% | -1,907.11% N/A | |
Return on Assets | -95.95% +14.00% | -84.17% N/A | N/A N/A | N/A N/A | |
Return on Equity | -186.64% +11.43% | -167.49% -18.52% | -205.55% +167.31% | -76.89% N/A | |
Revenue Growth | -1.90% -101.29% | 147.58% -21.30% | 187.52% +340.63% | -77.93% N/A | |
Current Ratio | 0.77 -50.60% | 1.57 +138.49% | 0.66 +185.68% | 0.23 N/A | |
Cash Ratio | 0.19 -83.52% | 1.16 +342.63% | 0.26 -89.69% | 2.53 N/A | |
Debt-to-Equity Ratio | 0.62 +137.12% | 0.26 +30.65% | 0.20 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.22 +42.52% | 0.16 +115.21% | 0.07 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow